Additionally, the combination of the CDK inhibitor SCH727965 and the Hsp90 inhibitor NVP-AUY922 induced apoptosis and cell cycle disruption in sarcoma cells, while it spared the normal osteoblasts [27]. Here, HSP90AA1 is linked to sarcoma.